YK-1002

N/A

Report date: 2025/06/04 11:51:18
NME

Base Information

Drug NameYK-1002
Drug Alias NameYK1002YK-1002
ClassificationSmall molecules
Mechanisms of ActionV-domain Ig suppressor of T-cell activation inhibitors
TargetsV-domain Ig suppressor of T-cell activation
Therapy Area/IndicationsStomach NeoplasmsColonic NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYaokang Zhongtuo (Beijing) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYaokang Zhongtuo (Beijing) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsColonic NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A